comparemela.com

Latest Breaking News On - Susquehanna fundamental investments - Page 10 : comparemela.com

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) to Post Q2 2024 Earnings of ($1.28) Per Share, HC Wainwright Forecasts

Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) – Equities research analysts at HC Wainwright lowered their Q2 2024 earnings estimates for shares of Inovio Pharmaceuticals in a report released on Tuesday, May 14th. HC Wainwright analyst R. Selvaraju now forecasts that the biopharmaceutical company will post earnings of ($1.28) per share for the quarter, down […]

Canada
Inovio-pharmaceuticals-inc
News-ratings-for-inovio-pharmaceuticals-daily
Nasdaq
Inovio-pharmaceuticals-trading-down
Pathstone-family-office
Inovio-pharmaceuticals
Keystone-financial-group
Capital-investment-advisors
Vanguard-personalized-indexing-management
Susquehanna-fundamental-investments

Canoo (NASDAQ:GOEV) PT Lowered to $3.00 at Roth Mkm

Canoo (NASDAQ:GOEV – Free Report) had its price target lowered by Roth Mkm from $4.00 to $3.00 in a research note published on Wednesday morning, Benzinga reports. The firm currently has a neutral rating on the stock. A number of other equities research analysts have also issued reports on GOEV. Alliance Global Partners cut their […]

United-states
Switzerland
Swiss
Roth-mkm
Stifel-nicolaus
Kestra-advisory-services
Susquehanna-fundamental-investments
Canoo-inc
Swiss-national-bank
Sg-americas-securities
Ep-wealth-advisors
Alliance-global-partners

Pixelworks (NASDAQ:PXLW) PT Lowered to $3.00 at Craig Hallum

Pixelworks (NASDAQ:PXLW – Free Report) had its price target lowered by Craig Hallum from $4.00 to $3.00 in a report issued on Wednesday, Marketbeat.com reports. Craig Hallum currently has a buy rating on the semiconductor company’s stock. Several other equities analysts also recently weighed in on the stock. Needham & Company LLC reduced their target […]

United-states
Japan
China
Taiwan
Craig-hallum
Roth-mkm
Susquehanna-fundamental-investments
Traynor-capital-management-inc
Connor-clark-lunn-investment-management-ltd
Essex-investment-management-co
Nasdaq
Needham-company

Heron Therapeutics, Inc. (NASDAQ:HRTX) Expected to Post FY2026 Earnings of $0.20 Per Share

Heron Therapeutics, Inc. (NASDAQ:HRTX) Expected to Post FY2026 Earnings of $0.20 Per Share
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Heron-therapeutics-inc
Victory-capital-management-inc
Susquehanna-fundamental-investments
Needham-company
Commonwealth-equity-services
Nasdaq
Headlands-technologies
Pricet-rowe-associates-inc
Heron-therapeutics-company-profile
Heron-therapeutics
Free-report

Tango Therapeutics (NASDAQ:TNGX) Shares Down 3.7%

Tango Therapeutics (NASDAQ:TNGX) Shares Down 3.7%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Piper-sandler
Tango-therapeutics-company-profile
Tango-therapeutics-inc
Vanguard-group-inc
Cantor-fitzgerald
Mva-investors-llc
Pricet-rowe-associates-inc
Paloma-partners-management-co
Nasdaq
Artal-group
Securities-exchange-commission
Susquehanna-fundamental-investments

vimarsana © 2020. All Rights Reserved.